FTRE DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 1 Deadline in Securities Class Action – FTRE — Neutral
FTRE GlobeNewsWire — July 25, 2025NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”), of the important August 1, 2025 lead plaintiff deadline.
Integer Holdings Q2 Earnings Miss Estimates, Revenues Up Y/Y — Neutral
ITGR Zacks Investment Research — July 25, 2025ITGR posts strong second-quarter revenue growth, but EPS misses estimate despite solid segment momentum.
Bread Financial Q2 Earnings Beat, Revenues Miss, Credit Sales Rise — Positive
BFH Zacks Investment Research — July 25, 2025BFH tops Q2 EPS estimates by nearly 70% as credit sales rise, even as revenues dip on lower finance charges and late fees.
Final Trades: Gilead, Blackstone, Disney and Visa — Neutral
BX DIS GILD V CNBC Television — July 25, 2025The Investment Committee give you their top stocks to watch for the second half.
The aggressive expansion for Palazzo signals confidence in Asian gaming markets. Non-stop growth in Asia highlights strong demand for integrated resorts and entertainment. Strategic investments position the company to capture emerging opportunities in the region.
Cytokinetics continues to near unaminous positive analyst sentiment, with most price targets well above current levels, reflecting strong growth expectations. The company's NDA around its lead drug candidate was delayed by three months recently. However, Cytokinetics maintains a robust cash position of $1.1 billion, supporting ongoing operations and R&D. If all goes according to schedule, Cytokinetics should receive the first of many FDA approvals late this year and has several potential catalysts on the horizon.
The company ended its second quarter with $797.5 million in cash and extended its cash runway into 2029.
ServiceNow's NYSE: NOW Q2 results and guidance update are a wow moment for investors and an eye-opener for those waiting on AI's second wave. The second wave, the rise of agentic services and the application of AI, is expected to be a larger, faster-growing, and longer-sustained rally than infrastructure, which has been a rocket-ship of gains for technology investors.
Should You Buy, Sell, or Hold Vertiv Stock Before Q2 Earnings? — Positive
VRT Zacks Investment Research — July 25, 2025VRT benefits from AI-driven demand with strong Q2 growth expected, but stretched valuation may give investors pause ahead of earnings.
Rigetti Gains 44% in 1 Month: Is Investor Sentiment Starting to Shift? — Positive
RGTI Zacks Investment Research — July 25, 2025RGTI jumps 44% in a month after hitting a major quantum milestone, as investors eye its chiplet-based 100+ qubit roadmap.
Surging Earnings Estimates Signal Upside for Western New England Bancorp (WNEB) Stock — Positive
WNEB Zacks Investment Research — July 25, 2025Western New England Bancorp (WNEB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Surging Earnings Estimates Signal Upside for NB Bancorp, Inc. (NBBK) Stock — Positive
NBBK Zacks Investment Research — July 25, 2025NB Bancorp, Inc. (NBBK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Synovus (SNV) Might be Well Poised for a Surge — Positive
SNV Zacks Investment Research — July 25, 2025Synovus Financial (SNV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Can Hagerty (HGTY) Run Higher on Rising Earnings Estimates? — Positive
HGTY Zacks Investment Research — July 25, 2025Hagerty, Inc. (HGTY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The Investment Committee debate the latest Calls of the Day.
Meta: Q2 Earnings Could Bring Another CapEx Increase
The 'Halftime' Investment Committee debate the speculative 'Big Tech' trade — Neutral
AAPL AMZN META MSFT CNBC Television — July 25, 2025The Investment Committee debate the speculative trade as we head into a big week of mega cap earnings next week.
Strength Seen in Broadridge Financial (BR): Can Its 4.3% Jump Turn into More Strength? — Positive
BR Zacks Investment Research — July 25, 2025Broadridge Financial (BR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
KNSL's Q2 Earnings, Revenues Beat Estimates, Premiums Rise Y/Y — Positive
KNSL Zacks Investment Research — July 25, 2025KNSL's Q2 EPS increases 27.5% to $4.78, beating estimates on disciplined underwriting and technology-enabled low costs.
SEGG Media: Three SEGG Stars Light Up Laguna Seca: Ilott, Foster, and Murray Set for Monterey Showdown — Neutral
LTRYW SEGG GlobeNewsWire — July 25, 2025MONTEREY, Calif., July 25, 2025 (GLOBE NEWSWIRE) -- A Media Snippet accompanying this announcement is available by clicking on this link.
